 |
인쇄하기
취소
|
'Herzuma', which is biosimilar product of ‘Herceptin’ for the breast cancer treatment has permitted
(Yakup Shinmoon)
Ministry of food and drug safety announced that on Jan 15, they permitted the biosimilar product 'Herzuma' which Celltrion had developed. Herzuma is first biosimilar product in the world that has anti-cancer effect.
It is biosimilar product of the breast cancer treatment, 'Herceptin'.
In the case of domestic, 'Herzuma' is the second biosimilar product followed by 'Rem...
Ministry of food and drug safety announced that on Jan 15, they permitted the biosimilar product 'Herzuma' which Celltrion had developed. Herzuma is first biosimilar product in the world that has anti-cancer effect.
It is biosimilar product of the breast cancer treatment, 'Herceptin'.
In the case of domestic, 'Herzuma' is the second biosimilar product followed by 'Rem...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.